Lawrence D Kaplan

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi HIV-associated lymphoma
    Lawrence D Kaplan
    Adult Lymphoma Program, University of California, San Francisco, CA 94143, USA
    Best Pract Res Clin Haematol 25:101-17. 2012
  2. pmc Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
    Lawrence D Kaplan
    Division of Hematology Oncology, University of California, 400 Parnassus Ave, Rm A 502, San Francisco, CA 94143, USA
    Blood 106:1538-43. 2005
  3. ncbi Current status of the treatment of HIV-associated lymphoma
    Lawrence D Kaplan
    University of California, San Francisco, USA
    Clin Adv Hematol Oncol 2:28-9. 2004
  4. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, San Francisco General Hospital, 94110, USA
    Oncology (Williston Park) 16:657-65; discussion 665, 668-70. 2002
  5. ncbi Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2003. A 44-year-old man with HIV infection and a right atrial mass
    Lawrence D Kaplan
    Division of Hematology Oncology, Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, USA
    N Engl J Med 349:1369-77. 2003
  6. doi Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium
    Brett T Brinker
    Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    Cancer 112:1083-8. 2008
  7. ncbi Biology and management of AIDS-associated non-Hodgkin's lymphoma
    Amy E Gates
    Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA
    Hematol Oncol Clin North Am 17:821-41. 2003
  8. ncbi AIDS-related lymphoproliferative disease
    Willis H Navarro
    Division of Hematology Oncology, University of California, San Francisco, 400 Parnassus Ave, Rm A502, San Francisco, CA 94143, USA
    Blood 107:13-20. 2006
  9. ncbi Advances in the management of HIV-related non-Hodgkin lymphoma
    Caroline M Behler
    Division of Hematology and Oncology, University of California, San Francisco, CA 94143 1270, USA
    Curr Opin Oncol 18:437-43. 2006
  10. pmc Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)
    James L Rubenstein
    Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
    J Clin Oncol 31:3061-8. 2013

Collaborators

Detail Information

Publications14

  1. doi HIV-associated lymphoma
    Lawrence D Kaplan
    Adult Lymphoma Program, University of California, San Francisco, CA 94143, USA
    Best Pract Res Clin Haematol 25:101-17. 2012
    ....
  2. pmc Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
    Lawrence D Kaplan
    Division of Hematology Oncology, University of California, 400 Parnassus Ave, Rm A 502, San Francisco, CA 94143, USA
    Blood 106:1538-43. 2005
    ..However, these benefits may be offset by an increase in infectious deaths, particularly in those individuals with CD4(+) lymphocyte counts less than 50/mm(3)...
  3. ncbi Current status of the treatment of HIV-associated lymphoma
    Lawrence D Kaplan
    University of California, San Francisco, USA
    Clin Adv Hematol Oncol 2:28-9. 2004
  4. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, San Francisco General Hospital, 94110, USA
    Oncology (Williston Park) 16:657-65; discussion 665, 668-70. 2002
    ..This two-part article, which began in the April 2002 issue, analyzes the impact of HAART on the incidence, clinical course, and outcomes of each of the AIDS-related malignancies...
  5. ncbi Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2003. A 44-year-old man with HIV infection and a right atrial mass
    Lawrence D Kaplan
    Division of Hematology Oncology, Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, USA
    N Engl J Med 349:1369-77. 2003
  6. doi Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium
    Brett T Brinker
    Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    Cancer 112:1083-8. 2008
    ....
  7. ncbi Biology and management of AIDS-associated non-Hodgkin's lymphoma
    Amy E Gates
    Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA
    Hematol Oncol Clin North Am 17:821-41. 2003
    ..Whether outcomes are improved with combination chemotherapy and HAART remains unclear. Efforts aimed at developing pathogenic-based therapies will continue as the mechanisms of HIV lymphomagenesis are elucidated...
  8. ncbi AIDS-related lymphoproliferative disease
    Willis H Navarro
    Division of Hematology Oncology, University of California, San Francisco, 400 Parnassus Ave, Rm A502, San Francisco, CA 94143, USA
    Blood 107:13-20. 2006
    ..Significant progress has been made in the understanding and management of ARL but outcomes still remain inferior compared to those achieved in HIV- individuals...
  9. ncbi Advances in the management of HIV-related non-Hodgkin lymphoma
    Caroline M Behler
    Division of Hematology and Oncology, University of California, San Francisco, CA 94143 1270, USA
    Curr Opin Oncol 18:437-43. 2006
    ..Even with a decrease in AIDS-defining illnesses after the advent of highly active antiretroviral therapy, HIV-associated non-Hodgkin lymphoma remains an important problem...
  10. pmc Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)
    James L Rubenstein
    Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
    J Clin Oncol 31:3061-8. 2013
    ....
  11. ncbi AIDS malignancies in the era of highly active antiretroviral therapy
    Amy E Gates
    University of California, San Francisco, USA
    Oncology (Williston Park) 16:441-51, 456, 459. 2002
    ..This two-part article, which will conclude in the May 2002 issue, analyzes the impact of HAARTon the incidence, clinical course, and outcomes of each of the AIDS-related malignancies...
  12. ncbi The case for rituximab in AIDS-related lymphoma
    Kieron Dunleavy
    Blood 107:3014-5. 2006
  13. ncbi Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020
    Thomas R Spitzer
    Bone Marrow Transplant Program, Massachusetts General Hospital, 0 Emerson Place, Suite 118, 55 Fruit Street, Boston, MA 02114, USA
    Biol Blood Marrow Transplant 14:59-66. 2008
    ....
  14. ncbi Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care
    Lawrence D Kaplan
    Am J Med 112:320-1. 2002